Welcome to Czar Gets Crypto! Please note the following:
1 extracted signal · 1 resolved · 0 still active
C-Zar Gets Crypto Independent analyst profile- Source published
- 31 Aug 2025, 21:53 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analyst discusses Zebec Network (ZBCNUSDT). The current price is $0.0038638. A Fibonacci retracement from a low to a high suggests potential support at $0.0037. If the price fails to hold at $0.0037, further drops towards $0.00309 are possible, with a 5-20% drop underway. Daily RSI indicates an oversold zone could trigger a bounce. One-hour indicators (RSI, stochastic, MACD) appear bearish, suggesting that bullish divergence may have already played out with the minor move to $0.0039. To validate the low, a four-hour or higher close above $0.0047 is needed. A potential pump to $0.0041576 could occur before further declines. Without Fibs, it's a potential area of support/resistance, and with the ABCD correction in mind it will ultimately go to the 0.0035 area. By October the predicted target of the upside is $0.0197. Once past $0.006, the climb really takes off.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
C-Zar Gets Crypto
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
